0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Interference by Phenazopyridine With the Leukocyte Esterase Dipstick

Jamie E. Kerr, MD; Carrie Magee-Nolan, BSN, MS; Barbara L. Schuster, MD
JAMA. 1986;256(1):38-39. doi:10.1001/jama.1986.03380010042017.
Text Size: A A A
Published online

To the Editor.—  The leukocyte esterase dipstick (Chemstrip 9) has been shown to be a sensitive screening test for pyuria and hematuria in symptomatic1 and asymptomatic2 patients. In an attempt to develop a cost-effective approach to this problem in a university health service, all female patients complaining of dysuria were screened with the dipstick. One hundred consecutive symptomatic females were screened from August 1985 through November 1985. The dipstick results were compared with microscopic examinations and culture results. Leukocyte chamber counts were not obtained because this test is not routinely available in most primary care ambulatory settings.

Report of a Study.—  Four patients reported taking phenazopyridine hydrochloride (Pyridium) within 24 hours of the laboratory evaluation. Two (50% ) of the four urine specimens had negative leukocyte esterase readings, with microscopic urinalyses showing 13 and 17 white blood cells per high-power field (WBCs/hpf). Culture results showed more than 100 000

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

51 Views
0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
×
brightcove.createExperiences();